Ethos and Raiffeisen Group Support Carbon Disclosure Project: New Survey on Swiss Listed Companies’ Climate Strategy

Investors increasingly take into account information about companies' climate change strategy to support their investment decisions. To this end, Ethos and the Raiffeisen Group are conducting a survey on CO2 reduction among the hundred largest listed companies in Switzerland. This survey in the framework of the Carbon Disclosure Project (CDP) - the largest international group of shareholders worldwide – is being conducted in Switzerland for the fourth time.

Climate Change: Swiss Listed Companies Can Do Much More

The Ethos Foundation and Pictet Asset Management are publishing today the results of the third survey on the climate strategies of Swiss listed companies (Carbon Disclosure Project). Only 56% of the companies approached agreed to provide investors with the relevant data – a relatively modest participation rate, in line, however, with that of the previous year (57%).

Swiss Companies and Climate Change: Rising Awareness, but Challenges Remain

Pictet and Ethos present the results of the Carbon Disclosure Project's second survey for Switzerland, which was distributed to the country's 100 biggest listed companies. The companies were asked about their climate change strategies and their data on greenhouse gas emissions. The survey shows that while most are aware of the issue, only a minority has put in place a convincing strategy or set concrete carbon reduction targets.

Principles for Responsible Investment: Ethos Obtains Top Scores

Ethos has received top marks in the annual Report on Progress detailing the implementation of the six United Nations Principles for Responsible Investment. It is ranked in the group of leaders for each of the six principles, and even obtains the highest possible mark with respect to three principles. This is a recognition by the financial community of Ethos' initiatives for sustainable investment and responsible ownership practices.

Access to Medicine Index: Publication of Outcomes

Access to medicines in developing countries is one of the biggest challenges currently facing pharmaceutical companies. Ethos and several other institutional investors are aware of this and therefore support the Access to Medicine Index, an international initiative whose goal is to measure and compare how the different pharmaceutical companies approach policy on access to medicines. Roche and Novartis are singled out for their conservative position on patent protection.

Carbon Disclosure Project’s first Switzerland report on climate change: a challenge for Swiss companies

Within the framework of the Carbon Disclosure Project (CDP), the Ethos Foundation and Pictet Asset Management present the results of a survey of the 50 largest Swiss listed companies' climate change strategy. An analysis of the results reveals that while most of the companies have started to integrate climate change issues, the initiatives they take are still limited to production and do not extend to the companies' entire value chain.
Subscribe to Sustainable development